Key result
Implantable cardioverter-defibrillators have improved significantly in design and functionality, leading to a forecast of approximately 30,000 implants in the United States in 1995.
Highlights the rapid technological evolution of ICDs and their growing adoption in the mid-1990s.
An American view Use of the implantable defibrillatorTen years ago implantable cardioverter-defibrillators (ICDs) were cumbersome, required thoracotomy for placement of the epicardial patches, used only high energy shocks for treatment, and had short battery lives.Current devices are smaller and have lead systems that do not require thoracotomy.They also have facilities for antitachycardia pacing, low energy cardioversion, high energy defibrillation, backup bradycardia pacing, and documentation of the treated arrhythmias-and the bat- teries last longer.These improvements have added to the appeal of this treatment, and in the United States it is forecast that about 30 000 ICDs will be implanted in 1995.
No takes yet. Share an insight, caveat, or question.
Hammil et al. (1995) reported an editorial. Implantable cardioverter-defibrillators (ICDs) was evaluated. Implantable cardioverter-defibrillators have improved significantly in design and functionality, leading to a forecast of approximately 30,000 implants in the United States in 1995.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: